Ken Griffin acquired 156 Thousand Reata Pharmaceuticals shares worth $14.4 Million. That's 0.02% of their equity portfolio (976th largest holding). The first Reata Pharmaceuticals trade was made in Q3 2017. Since then Ken Griffin bought shares 36 more times and sold shares on 21 occasions. The stake costed the investor $10.6 Million, netting the investor a gain of 36% so far.